A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti- MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1)

Project: Research

Project Details

StatusActive
Effective start/end date31/10/24 → 30/10/26

Keywords

  • Clinical Trials
  • CN0080003